Shopping Cart 0
Cart Subtotal
USD 0

IPCA Laboratories Ltd (IPCALAB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

IPCA Laboratories Ltd (IPCA) is a pharmaceutical company which manufactures and markets active pharmaceutical ingredients, generics and formulations for various therapeutic areas. The company's active pharmaceutical ingredients include anti-hypertensive, anti-malarial, diuretic and anthelmintic products, among others. It also provides generic and branded formulations including oral solids and liquids, dry powders for suspension and injectables. IPCA's products targets various disease areas such as acne, brain disease, fever, pain, malaria, mental illness, urinary disease, stomach ailments, heart ailment and rheumatoid arthritis, among others. It has operations and manufacturing facilities across India, Colombia, Kazakhastan, Sri Lanka, Vietnam, Russia, Kenya, and others. IPCA is headquartered in Mumbai, Maharashtra, India.

IPCA Laboratories Ltd (IPCALAB)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

IPCA Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Ipca Labs Acquires Oral Solid Dosage Formulations Manufacturing Unit from Alpa Labs for USD11.5 Million 11

Partnerships 12

Nuformix Extends Agreement with Onyx Scientific 12

Amyris to Enter into Co-Development Agreement with Ipca Labs 13

Molecular Profiles Enters Into Agreement With Onyx Scientific 14

Licensing Agreements 15

Ipca Labs Enters into Licensing Agreement with Oncobiologics for ONS-1050 15

Ipca Labs Amends Licensing Agreement with Oncobiologics 16

Debt Offering 17

Ipca Labs Completes Private Placement Of Debentures For USD 4 Million 17

Acquisition 18

Ipca Pharma Acquires 80% Stake in Bayshore Pharma for USD10.3 Million 18

Ipca Pharma and Onyx Scientific Acquire Pisgah Labs for USD9.6 Million 19

Ipca Laboratories Acquires Additional 26% Stake in Krebs Biochemicals 20

Khazanah Nasional Acquires Minority Stake in Ipca Labs for USD40 Million 21

Ipca Labs To Acquire 50% Stake In Avik Pharma For USD 1 Million 23

Ipca Labs Completes Acquisition Of Remaining 67.7% Stake In Tonira Pharma For USD 2.2 Million 24

IPCA Laboratories Ltd-Key Competitors 25

IPCA Laboratories Ltd-Key Employees 26

IPCA Laboratories Ltd-Locations And Subsidiaries 27

Head Office 27

Other Locations & Subsidiaries 27

Recent Developments 29

Financial Announcements 29

May 29, 2018: Ipca Laboratories: Audited FY18 Financial Results 29

Feb 07, 2018: Ipca Laboratories Q3 FY18 Financial Results 30

Nov 14, 2017: Ipca Laboratories Q2 FY18 Financial Results 31

Aug 11, 2017: Ipca Laboratories Q1 FY18 Unaudited Financial Results 32

May 28, 2017: Ipca Laboratories Audited FY17 Financial Results 33

Legal and Regulatory 34

Jun 20, 2017: IPCA Laboratories: US FDA Update 34

Jun 15, 2017: IPCA Lab Provides Update on SEZ Indore and Piparia Manufacturing Units 35

Jun 15, 2017: IPCA Laboratories Provides Update on Ratlam manufacturing facility 36

Appendix 37

Methodology 37

About GlobalData 37

Contact Us 37

Disclaimer 37


List Of Figure

List of Figures

IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2

IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

IPCA Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

IPCA Laboratories Ltd, Deals By Therapy Area, 2012 to YTD 2018 8

IPCA Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Ipca Labs Acquires Oral Solid Dosage Formulations Manufacturing Unit from Alpa Labs for USD11.5 Million 11

Nuformix Extends Agreement with Onyx Scientific 12

Amyris to Enter into Co-Development Agreement with Ipca Labs 13

Molecular Profiles Enters Into Agreement With Onyx Scientific 14

Ipca Labs Enters into Licensing Agreement with Oncobiologics for ONS-1050 15

Ipca Labs Amends Licensing Agreement with Oncobiologics 16

Ipca Labs Completes Private Placement Of Debentures For USD 4 Million 17

Ipca Pharma Acquires 80% Stake in Bayshore Pharma for USD10.3 Million 18

Ipca Pharma and Onyx Scientific Acquire Pisgah Labs for USD9.6 Million 19

Ipca Laboratories Acquires Additional 26% Stake in Krebs Biochemicals 20

Khazanah Nasional Acquires Minority Stake in Ipca Labs for USD40 Million 21

Ipca Labs To Acquire 50% Stake In Avik Pharma For USD 1 Million 23

Ipca Labs Completes Acquisition Of Remaining 67.7% Stake In Tonira Pharma For USD 2.2 Million 24

IPCA Laboratories Ltd, Key Competitors 25

IPCA Laboratories Ltd, Key Employees 26

IPCA Laboratories Ltd, Other Locations 27

IPCA Laboratories Ltd, Subsidiaries 27

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

IPCA Laboratories Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.